Search Tag: glucose-lowering therapies

Cardiology Management

Glucose-lowering-therapies-in-patients-with-diabetes-and-heart-failure

2018 02 Apr

Despite multiple examples of glucose-lowering therapies affecting heart failure (HF) risk, ascertainment of HF data in cardiovascular (CV) outcome trials of these medications has not been systematically characterised, according to a review published in the Journal of the American College of Cardiology. "Even recently completed large CV outcome trials...Read more

Cardiology Management

Diabetes-mellitus-and-heart-failure

2017 05 Jun

Considering current trial results, patients with diabetes and heart failure may benefit most from glucose-lowering therapies with sodium glucose cotransporter 2 (SGLT2) inhibition, according to a review paper to appear in the American Journal of Cardiology. The beneficial effects of such therapies may be due to "the elimination of glucose via the...Read more